Around 1 in 8 people in the UK are affected by the more serious form of fatty liver disease, metabolic dysfunction-associated steatohepatitis (MASH). This is closely linked with being overweight as well as conditions such as type 2 diabetes and heart and circulatory disease. This session will provide an overview of the condition, the latest guidelines for testing, case studies, and treatment.